Thamolwan Surakiatchanukul, MD | |
115 Lincoln St, Framingham, MA 01702-6358 | |
(508) 383-1555 | |
Not Available |
Full Name | Thamolwan Surakiatchanukul |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 115 Lincoln St, Framingham, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902398415 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 272887 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Thamolwan Surakiatchanukul, MD 852 W Main St Apt 321, Charlottesville, VA 22903-3497 Ph: () - | Thamolwan Surakiatchanukul, MD 115 Lincoln St, Framingham, MA 01702-6358 Ph: (508) 383-1555 |
News Archive
A team of researchers at the University of Hong Kong said that they have proven that a 33-year-old man was infected by the SARS-CoV-2 virus for a second time. The man was discharged from a hospital in April but contracted the infection again after returning from Spain via the United Kingdom in August.
Scientists may now be able to predict whether carrying a specific genetic variant increases a person's risk for disease using gene editing and stem cell technologies, according to new research in the American Heart Association's journal Circulation.
New estimates suggest that 20 to 30 percent of opioid analgesic drugs prescribed for chronic pain are misused, while the rate of opioid addiction is approximately 10 percent, reports a study in the April issue of PAIN, the official journal of the International Association for the Study of Pain.
Nanosys, Inc. today announced it has agreed to settlement terms of a patent infringement lawsuit against Nanoco Technologies Ltd.
Gloucester Pharmaceuticals announced today that the Oncologic Drug Advisory Committee (ODAC) appointed by the U.S. Food and Drug Administration (FDA) voted 10 in favor with one abstention to recommend approval of romidepsin to treat patients with cutaneous T-cell lymphoma (CTCL). CTCL is a type of non-Hodgkin's lymphoma, which is a cancer of the immune system.
› Verified 3 days ago
Dr. Wendy Elizabeth Gray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Cochituate Rd, Framingham, MA 01701 Phone: 508-628-9660 Fax: 508-628-9668 | |
Dr. Sira Korpaisarn, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1130 | |
Dagem Getahun, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1555 | |
Dr. Pedro Arthur Macedo De Freitas, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1000 | |
Yung-chen Wu, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Lincoln St, Framingham, MA 01702 Phone: 508-383-1572 | |
Richard Stephen Blumenfeld, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 761 Worcester Rd, Framingham, MA 01701 Phone: 508-879-7904 Fax: 508-872-8594 | |
Rejane Guerrier, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 959 Concord St Ste 200, Framingham, MA 01701 Phone: 508-532-0223 Fax: 508-875-0049 |